| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 53.3802 | 57 |
| GSM780708 | Untreated after 4 days (C2_1) | 48.6436 | 44 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.7882 | 36 |
| GSM780719 | Untreated after 4 days (C1_2) | 46.0888 | 32 |
| GSM780720 | Untreated after 4 days (C2_2) | 49.3527 | 46 |
| GSM780721 | Untreated after 4 days (C3_2) | 55.3876 | 60 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 47.6688 | 40 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 49.6254 | 47 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 48.9295 | 45 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.401 | 43 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 52.2185 | 54 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 50.1658 | 49 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 46.4878 | 34 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 53.4851 | 57 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 46.5859 | 35 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 51.4588 | 53 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 59.4783 | 64 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 57.7508 | 63 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49.1232 | 45 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 51.7788 | 53 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 53.5937 | 57 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 50.6386 | 50 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 53.289 | 57 |